Stomach Cancer Trial, Recruiting NCT07561073 Sponsor: Guangxi Medical University Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT07561073
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Patients and their families have been fully informed about the study and have voluntarily agreed to take part by signing a consent form.
  • People aged between 18 and 75 years old (including those who are exactly 18 or 75).
  • People who have been diagnosed through tissue testing with advanced stomach cancer (specifically cancer in the lower part of the stomach, classified as stage IV) that has spread locally or to distant parts of the body or the lining of the abdomen, and where surgery to fully remove the cancer is not possible.
  • People who have a blockage in their digestive tract (confirmed by X-ray or a camera examination of the stomach), with a low score on a scale used to measure how well food and liquid can pass through (GOOSS score of 1 or below).
  • People whose general physical condition and ability to carry out daily activities falls within a certain range on a standard medical scale (ECOG score of 0–2), and this has been stable for at least 7 days.
  • People whose overall surgical risk falls within a certain accepted range on a standard assessment scale (ASA score of I to III).
  • People who have not previously received any anti-cancer treatment, such as radiation, chemotherapy, targeted therapy, or immunotherapy.
  • People whose key organ functions meet specific blood and laboratory test requirements, including healthy enough levels of blood cells, liver function, kidney function, heart function, and blood clotting ability (confirm specific values with the trial site).
  • Women who are able to become pregnant must be using effective contraception.
  • People who have no other medical reasons that would make surgery unsafe.
  • People who are willing and able to attend follow-up appointments and cooperate with the study requirements.

Who may not be able to join:

  • People who are unable or unwilling to follow the study plan or its procedures.
  • People who have had another type of cancer in the past 5 years, except for certain skin cancers or early-stage cervical cancer that were fully treated with surgery.
  • People who have an active autoimmune disease (where the immune system attacks the body), or who have had one in the 4 weeks before joining the study.
  • People who have previously had a bone marrow transplant or an organ transplant from another person.
  • People who have had a serious heart condition in the past 6 months, such as a heart attack, severe chest pain, heart bypass surgery, or significant heart failure, or who have an irregular heartbeat requiring medication, or whose heart pumping strength falls below a certain level.
  • People who have a serious active infection that is not under control.
  • People known to have HIV, active hepatitis B, or active hepatitis C infection (as determined by specific blood test results — confirm details with the trial site).
  • People who are pregnant (confirmed by a test before treatment) or who are currently breastfeeding.
  • People who have any other serious medical condition, unusual test results, or health situation that the research doctors believe would make participation unsafe or affect the study's results.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +867715310421

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Guangxi Medical University
Registry
ClinicalTrials.gov
Start date
20 August 2026
Est. completion
1 January 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of delayed gastric emptying(DGE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov